AES Antikörper (C-Term)

Produktnummer ABIN629632

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch AES in WB. Er zeigt eine Reaktivität gegenüber Human, Maus, Ratte und Hund.

Kurzübersicht für AES Antikörper (C-Term) (ABIN629632)

Target: AES (Amino-terminal Enhancer of Split (AES))

Reaktivität: Human, Maus, Ratte, Hund

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser AES Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-AES Antikörper

Bindungsspezifität: C-Term

Spezifität: AES antibody was raised against the C terminal of AES

Aufreinigung: Purified

Immunogen: AES antibody was raised using the C terminal of AES corresponding to a region with amino acids GLQPPSLPAVSAGTGLLSLSALGSQAHLSKEDKNGHDGDTHQEDDGEKSD

Anwendungsinformationen

Applikationshinweise: WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

AES Blocking Peptide, (ABIN938800), is also available for use as a blocking control in assays to test for specificity of this AES antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of AES antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu AES

Target: AES (Amino-terminal Enhancer of Split (AES))

Andere Bezeichnung: AES

Hintergrund: AES is similar in sequence to the amino terminus of Drosophila enhancer of split groucho, a protein involved in neurogenesis during embryonic development. The protein, which belongs to the groucho/TLE family of proteins, can function as a homooligomer or as a heteroologimer with other family members to dominantly repress the expression of other family member genes.

Molekulargewicht: 22 kDa (MW of target protein)

Pathways: WNT Signalweg, SARS-CoV-2 Protein Interaktom